RCT A - Atrial Flutter without Hydrops

RCT B - Treatment Arms

RCT B ARM 1: DIGOXIN

 

0.5 mg Digoxin q 12 hrs

(total 4 doses over 48 hrs) 

Aim: therapeutic maternal trough level of 1.0-2.0 ng/ml or 1.3-2.6 nmol/L

 

RCT B ARM 2: FLECAINIDE

 

100 mg Flecainide (TID) (300 mg/day)

 

Note: See study protocol for specific treatment information and recommendations.

RCT B - SVT without Hydrops

RCT B Care Map

Screening of study eligibility

Randomization by sites in REDCap

Treatment start with 1st line study drug

Clinical and ultrasound assessments

Use recommended 1st line therapy for 3 to 7 days unless earlier changes are clinically indicated

A) to d) represent possible early outcome scenarios and recommended treatment adjustments 

Note: Please refer to your study protocol and study documents for country specific procedures and guidelines. The on-line text is a general information guide only.